Home > Healthcare > Healthcare IT > Health Services > econsent in healthcare market
Get a free sample of eConsent in Healthcare Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of eConsent in Healthcare Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The shift towards digital health records and electronic processes is part of a broader movement towards digital transformation in the healthcare industry, aiming to improve efficiency, accuracy, and patient experience.
The eConsent in healthcare industry size was valued at USD 458.2 million in 2023 and is anticipated to witness 10.6% CAGR through 2032 driven by the expansion and globalization of clinical trials, increasing awareness among patients, and the rise of telehealth and remote care services.
The cloud-based deployment mode segment held 76.7% of the market share in 2023 as their accessibility enhances patient engagement and streamlines administrative workflows for healthcare providers.
North America eConsent in healthcare industry size was valued at USD 200.6 million in 2023 and is predicted to grow at 10.1% CAGR from 2024 to 2032, driven by technological advancements, stringent regulatory frameworks, and a strong emphasis on patient-centric care.
Advarra, Calysta EM, Castor, Climedo Health GmbH, Clinical ink, Concentric Health Ltd, Epic Communications, EvidentIQ Group GmbH, Florence Healthcare, and Interlace Health